Long-Term Mortality in Different Age Groups of Patients with Infective Endocarditis Who Undergo Aortic Root Replacement: A Nationwide Study
DOI:
https://doi.org/10.1532/hsf.4555Keywords:
Aortic root replacement, Infective endocarditis, Registry-based study, Age groupsAbstract
Background: Infective endocarditis (IE) with involvement of the aortic root is associated with high short-term mortality and morbidity. Long-term data are sparse, and the existing studies with long-term data are restricted by a low number of patients and do not report mortality risks of different age groups.
Objective: This study examined the all-cause mortality risk postoperatively of patients with first-time IE who underwent aortic root replacement (ARR), according to age at the time of surgery, with one and 10 years follow-up.
Methods: Patients with first-time IE who underwent ARR surgery from 2000-2016 were identified in Danish nationwide administrative registries and divided into age groups: ≤60, 61-74, and ≥75 years. We compared one- and 10-year mortality risk using multivariable Cox regression across the three age groups.
Results: We identified 258 patients who underwent ARR (26.0% female, 42.6% with prosthetic valves, median age 64 years (IQR 55-73), of whom 98, 112, and 48 patients were ≤60 years, 61-74 years, and >75 years, respectively. The corresponding in-hospital mortality risk was 10.2%, 22.3%, and 29.2% (P = .01), respectively. The one-year postoperative mortality risk was 17.3%, 28.6%, and 33.3% (P = 0.05), while at 10 years after surgery, it was 31.8%, 62.9%, and 77.1%
(P < 0.01), respectively. The adjusted 10-year hazard ratio was higher in the 61-74 and >75-year age groups (HR 1.94 [1.18-3.16] and 2.46 [1.35-4.49]) compared with the ≤60.
Conclusion: Aortic root replacement in patients with first-time IE was associated with a high in-hospital and one- and 10-year mortality with worse outcomes with age.
References
Anguera I, Miro JM, Evangelista A, et al. 2006. Periannular Complications in Infective Endocarditis Involving Native Aortic Valves. Am J Cardiol. 98(9):1254-1260.
Arnett EN, Roberts WC. 1976. Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation. 54(1):140-145.
Chen GJ, Lo WC, Tseng HW, Pan SC, Chen YS, Chang SC. 2018. Outcome of surgical intervention for aortic root abscess: A meta-analysis. Eur J Cardio-thoracic Surg. 53(4):807-814.
David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. 2007. Surgical treatment of active infective endocarditis: A continued challenge. J Thorac Cardiovasc Surg. 133(1):144-149.
David TE, Regesta T, Gavra G, Armstrong S, Maganti MD. 2007. Surgical treatment of paravalvular abscess: long-term results. Eur J Cardio-thoracic Surg. 31(1):43-48.
Di Marco L, Pacini D, Pantaleo A, et al. 2016. Composite valve graft implantation for the treatment of aortic valve and root disease: Results in 1045 patients. J Thorac Cardiovasc Surg. 152(4):1041-1048.e1.
Fayad G, Leroy G, Devos P, et al. 2011. Characteristics and prognosis of patients requiring valve surgery during active infective endocarditis. J Heart Valve Dis. 20(2):223-228.
Graupner C, Vilacosta I, SanRomán J, et al. 2002. Periannular extension of infective endocarditis. J Am Coll Cardiol. 39(7):1204-1211.
Helweg-Larsen K. 2011. The Danish register of causes of death. Scand J Public Health. 39(7):26-29.
Jassar AS, Bavaria JE, Szeto WY, et al. 2012. Graft selection for aortic root replacement in complex active endocarditis: Does it matter? Ann Thorac Surg. 93(2):480-487.
Knosalla C, Weng Y, Yankah AC, et al. 2000. Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess - 11 Year results. Eur Heart J. 21(6):490-497.
Lund O, Chandrasekaran V, Grocott-Mason R, et al. 1999. Primary aortic valve replacement with allografts over twenty-five years: Valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg. 117(1):77-91.
Martínez-Sellés M, Muñoz P, Arnáiz A, et al. 2014. Valve surgery in active infective endocarditis: A simple score to predict in-hospital prognosis. Int J Cardiol. 175(1):133-137.
McGiffin DC, Galbraith AJ, McLachlan GJ, et al. 1992. Aortic valve infection: Risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg. 104(2):511-520.
Moser C, Elming H, Helweg-Larsen J, et al. 2020. Behandlingsvejledning | Infektiøs endocarditis. https://nbv.cardio.dk.
Müller LC, Chevtchik O, Bonatti JO, Müller S, Fille M, Laufer G. 2003. Treatment of destructive aortic valve endocarditis with the freestyle aortic root bioprosthesis. Ann Thorac Surg. 75(2):453-456.
Musci M, Weng Y, Hübler M, et al. 2010. Homograft aortic root replacement in native or prosthetic active infective endocarditis: Twenty-year single-center experience. J Thorac Cardiovasc Surg. 139(3):665-673.
Nashef SAM, Roques F, Sharples LD, et al. 2012. EuroSCORE II. Eur J Cardio-Thoracic Surg. 41(4):734-745.
Nguyen DT, Delahaye F, Obadia JF, et al. 2010. Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses☆. Eur J Cardio-Thoracic Surg. 37(5):1025-1032.
Olmos C, Vilacosta I, Habib G, et al. 2017. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 103(18):1435-1442.
Ostergaard L, Adelborg K, Sundboll J, Pedersen L, Loldrup Fosbol E, Schmidt M. 2018. Positive predictive value of infective endocarditis in the Danish National Patient Registry: A validation study. Epidemiol Infect. 146(15):1965-1967.
Østergaard L, Smerup MH, Iversen K, et al. 2020. Differences in mortality in patients undergoing surgery for infective endocarditis according to age and valvular surgery. BMC Infect Dis. 20(1):705.
Özcan C, Juel K, Lassen JF, Mia Von Kappelgaard L, Mortensen PE, Gislason G. 2016. The Danish Heart Registry. Published online.
Pettersson GB, Coselli JS, Pettersson GB, et al. 2017. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 153(6):1241-1258.e29.
Ramos Tuarez FJ, Law MA. Cardiac Abscess. 2019. StatPearls Publishing.
Rasmussen L, Valentin J, Gesser KM, Hallas J, Pottegård A. 2016. Validity of the Prescriber Information in the Danish National Prescription Registry. Basic Clin Pharmacol Toxicol. 119(4):376-380.
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. 2015. The Danish National patient registry: A review of content, data quality, and research potential. Clin Epidemiol. 7:449-490.
Toumpoulis IK, Anagnostopoulos CE, Toumpoulis SK, DeRose JJ, Swistel DG. 2005. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg. 79(6):1902-1908.
Wallach Kildemoes H, Toft Sørensen H, Hallas J. 2011. The Danish national prescription registry. Scand J Public Health. 39(7):38-41.
